Zobrazeno 1 - 10
of 13
pro vyhledávání: '"E A, Albulova"'
Publikováno v:
Терапевтический архив, Vol 88, Iss 2, Pp 4-9 (2016)
Irritable bowel syndrome (IBS) is the most common diagnosis in gastroenterology. Over 10 years after Rome consensus III (2006), there has been much new information on the pathogenesis of IBS and its therapy options. The paper analyzes basic investiga
Externí odkaz:
https://doaj.org/article/fe5287a551f9434280bbd429d9d3041b
Autor:
O V Kniazev, A I Parfenov, A G Konopliannikov, I N Ruchkina, A A Churikova, S V Bykova, E A Albulova, O N Boldyreva, N A Fadeeva, A A Lishchinskaia
Publikováno v:
Терапевтический архив, Vol 87, Iss 2, Pp 39-44 (2015)
Aim. To compare the safety of therapy in patients with ulcerative colitis (UC) and Crohn's disease (CD) who have received combination anti-inflammatory therapy using bone marrow mesenchymal stromal cells (MSC) and standard therapy with 5-aminosalicyl
Externí odkaz:
https://doaj.org/article/f079545ef0244687b7988f936e1aca3b
Autor:
E A Albulova, V N Drozdov, Asfol'd Ivanovich Parfenov, Yu V Vyazhevich, A V Petrakov, G G Varvanina, A I Parfenov
Publikováno v:
Терапевтический архив, Vol 82, Iss 2, Pp 43-48 (2010)
Aim. to determine the frequency of development of osteopenia/ostoporosis (OP), vitamin D deficiency, some population risk factors, and the effects of α-calcidol and calcitriol on bone mineral density (BMD) in patients with gluten-sensitivity celiac
Externí odkaz:
https://doaj.org/article/342b58643ac24ec7b06760088711a055
Publikováno v:
Терапевтический архив, Vol 88, Iss 2, Pp 4-9 (2016)
Irritable bowel syndrome (IBS) is the most common diagnosis in gastroenterology. Over 10 years after Rome consensus III (2006), there has been much new information on the pathogenesis of IBS and its therapy options. The paper analyzes basic investiga
Autor:
A A Churikova, A A Lishinskaya, N A Fadeeva, A I Parfenov, E Yu Bondarenko, A. G. Konoplyannikov, E A Albulova, A V Kagramanova, O N Boldyreva, I N Ruchkina, S V Bykova, Oleg Knyazev
Publikováno v:
Journal of Clinical Practice. 5:5-14
There is a large amount of literature data that shows the effectiveness of cell therapy using mesenchymal stromal cells (MSCs), as on preclinical models and in some clinical studies in small groups of patients.Currently the use of MSC in clinical pra
Publikováno v:
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (2)
Carcinoid of the thin bowel is difficult to diagnose pathology. Complications diagnosticians with that doctors clash on ambulatory and hospital the stages, including at offtype clinical presentation of disease, result in late recognition of carcinoid
Publikováno v:
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (6)
There are shown results of studies of bone mineral density in patients with celiac disease. The problem of malabsorption syndrome with clinical and pathogenetic point of view, which can lead to bone loss due to on absorption violations of calcium and
Publikováno v:
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (3)
The article presents the results of a bone mineral density study in patients with glutensensitive celiac disease. Was discussed problem of malabsorption syndrome with clinical and pathogenetic point of view, which can lead to bone loss due to malabso
Autor:
Iu V, Embutnieks, V N, Drozdov, I V, Chernyshova, O N, Topcheeva, E S, Koricheva, E A, Albulova
Publikováno v:
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (2)
This article studies the clinical features of the flow of the gastrointestinal tract and liver in the formation of osteopenia and osteoporosis. Were shown the incidence of disorders of bone mineral density in patients with chronic pancreatitis, liver
Autor:
E A Albulova, Oleg Knyazev, I N Ruchkina, N A Fadeeva, A A Lishchinskaya, A I Parfenov, O N Boldyreva, A A Churikova, S V Bykova, A G Konoplyannikov
Publikováno v:
Терапевтический архив, Vol 87, Iss 2, Pp 39-44 (2015)
To compare the safety of therapy in patients with ulcerative colitis (UC) and Crohn's disease (CD) who have received combination anti-inflammatory therapy using bone marrow mesenchymal stromal cells (MSC) and standard therapy with 5-aminosalicylic ac